Onderneming Exicure Inc Other OTC
Aandelen
US30205M1018
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Immuno-oncology Therapeutics
100,0
%
| 0 | 100,0 % | 29 | 100,0 % | -6.068,12% |
Verkoop per regio
USD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 29 | 100,0 % | -6.068,12% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Paul Kang
CEO | Chief Executive Officer | 63 | 24-02-23 |
Ji-Young Hwang
DFI | Director of Finance/CFO | 47 | 01-12-22 |
Investor Relations Contact | 47 | - | |
Joshua Miller
AUD | Comptroller/Controller/Auditor | 48 | 01-04-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ji-Young Hwang
DFI | Director of Finance/CFO | 47 | 01-12-22 |
Paul Kang
CEO | Chief Executive Officer | 63 | 24-02-23 |
Hyuk Joon Ko
BRD | Director/Board Member | - | 23-08-23 |
Dongho Lee
BRD | Director/Board Member | - | 21-08-23 |
Hojoon Lee
BRD | Director/Board Member | - | 23-08-23 |
Minhee Eom
BRD | Director/Board Member | - | 26-09-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 8 648 307 | 4 753 248 ( 54,96 %) | 0 | 54,96 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,75% | 111 mld. | |
+11,26% | 106 mld. | |
-12,28% | 22,24 mld. | |
+0,44% | 21,25 mld. | |
-4,18% | 18,97 mld. | |
-37,85% | 18,52 mld. | |
-8,95% | 16,81 mld. | |
+38,75% | 12,54 mld. | |
-24,51% | 8,09 mld. |